Why Is RocketLab Stock Crashing, and is it a Buying Opportunity? | RKLB Stock Analysis
Summary
Parkev analyzes Rocket Lab's latest quarterly results, noting that the company achieved record revenues of $234 million, representing 62% year-over-year growth. Parkev emphasizes that the company's fundamentals are improving, with net losses narrowing to $49 million and a backlog that surged 137% to a record $2.36 billion. Parkev also highlights significant new contracts, including a $397 million deal with the US Space Force for satellite delivery.
Despite these positive business developments, Parkev focuses on a major disconnect between the company's performance and its market valuation. Parkev explains that the 7% post-earnings stock drop was a necessary valuation correction because the bar for success was set too high. Parkev notes that a forward price-to-sales ratio of 36 is exceptionally high compared to historical levels and the broader market, especially since growth is expected to slow from 54% this year to 32% by 2028.
Mentioned Stocks
Reasoning: Parkev states that Rocket Lab is an exceptionally innovative company that reported record revenues and a massive backlog growth. However, Parkev maintains a HOLD rating because the valuation is extremely high, trading at a forward price-to-sales ratio of 36. Parkev calculates a fair value of approximately $22 per share using a discounted cash flow model, which is significantly lower than the current market price of roughly $80.